Crossref journal-article
Rockefeller University Press
The Journal of Experimental Medicine (291)
Abstract

Posttranslational modification of peptide antigens has been shown to alter the ability of T cells to recognize major histocompatibility complex (MHC) class I–restricted peptides. However, the existence and origin of naturally processed phosphorylated peptides presented by MHC class I molecules have not been explored. By using mass spectrometry, significant numbers of naturally processed phosphorylated peptides were detected in association with several human MHC class I molecules. In addition, CD8+ T cells could be generated that specifically recognized a phosphorylated epitope. Thus, phosphorylated peptides are part of the repertoire of antigens available for recognition by T cells in vivo.

Bibliography

Zarling, A. L., Ficarro, S. B., White, F. M., Shabanowitz, J., Hunt, D. F., & Engelhard, V. H. (2000). Phosphorylated Peptides Are Naturally Processed and Presented by Major Histocompatibility Complex Class I Molecules in Vivo. The Journal of Experimental Medicine, 192(12), 1755–1762.

Authors 6
  1. Angela L. Zarling (first)
  2. Scott B. Ficarro (additional)
  3. Forest M. White (additional)
  4. Jeffrey Shabanowitz (additional)
  5. Donald F. Hunt (additional)
  6. Victor H. Engelhard (additional)
References 50 Referenced 182
  1. 10.1146/annurev.iy.11.040193.002155 / Annu. Rev. Immunol. / The biochemistry and cell biology of antigen processing and presentation by Germain (1993)
  2. 10.1111/j.1600-065X.1999.tb01353.x / Immunol. Rev. / The nature of the MHC class I peptide loading complex by Cresswell (1999)
  3. 10.1016/0952-7915(94)90028-0 / Curr. Opin. Immunol. / Structure of peptides associated with MHC class I molecules by Engelhard (1994)
  4. 10.1002/(SICI)1097-0215(19990827)82:5<669::AID-IJC9>3.0.CO;2-# / Int. J. Cancer. / Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100 by Skipper (1999)
  5. 10.1126/science.1546328 / Science. / Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry by Hunt (1992)
  6. 10.4049/jimmunol.151.5.2572 / J. Immunol. / Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling by Huczko (1993)
  7. {'key': '2023072509173878700_R7', 'first-page': '105', 'article-title': 'Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules', 'volume': '73', 'author': 'Appella', 'year': '1995', 'journal-title': 'Exper. Suppl. (Basel).'} / Exper. Suppl. (Basel). / Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules by Appella (1995)
  8. {'key': '2023072509173878700_R8', 'first-page': '127', 'article-title': 'Sequence analysis of peptides presented to the immune system by class I and class II MHC molecules', 'volume-title': 'Methods in Protein Analysis', 'author': 'Hunt', 'year': '1993'} / Methods in Protein Analysis / Sequence analysis of peptides presented to the immune system by class I and class II MHC molecules by Hunt (1993)
  9. {'key': '2023072509173878700_R9', 'first-page': '152', 'article-title': 'Isolation and characterization of naturally processed peptides bound by class II molecules and peptides presented by normal and mutant antigen-presenting cells', 'volume': '57', 'author': 'Sette', 'year': '1993', 'journal-title': 'Chem. Immunol.'} / Chem. Immunol. / Isolation and characterization of naturally processed peptides bound by class II molecules and peptides presented by normal and mutant antigen-presenting cells by Sette (1993)
  10. 10.1084/jem.183.2.527 / J. Exp. Med. / An HLA-A2–restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins by Skipper (1996)
  11. 10.1084/jem.187.1.37 / J. Exp. Med. / The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol by Mosse (1998)
  12. 10.1016/S1074-7613(00)80330-1 / Immunity. / The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition by Meadows (1997)
  13. 10.4049/jimmunol.160.5.2099 / J. Immunol. / Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residuesimplications for tumor vaccine development by Kittlesen (1998)
  14. 10.4049/jimmunol.163.12.6360 / J. Immunol. / Cutting edgethe HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique by Pierce (1999)
  15. 10.1084/jem.190.1.145 / J. Exp. Med. / Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo by Haurum (1999)
  16. 10.1128/jvi.66.7.3996-4002.1992 / J. Virol. / Posttranslational side chain modification of a viral epitope results in diminished recognition by specific T cells by Larson (1992)
  17. 10.1084/jem.189.11.1757 / J. Exp. Med. / Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I–restricted viral determinants by Chen (1999)
  18. {'key': '2023072509173878700_R18', 'first-page': '5144', 'article-title': 'The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene', 'volume': '58', 'author': 'Hogan', 'year': '1998', 'journal-title': 'Cancer Res.'} / Cancer Res. / The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene by Hogan (1998)
  19. 10.4049/jimmunol.163.7.3812 / J. Immunol. / Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL by Andersen (1999)
  20. {'key': '2023072509173878700_R20', 'first-page': '2731', 'article-title': 'Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lungepitope reconstitution with peptides extracted from HLA-Aw68', 'volume': '54', 'author': 'Slingluff', 'year': '1994', 'journal-title': 'Cancer Res.'} / Cancer Res. / Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lungepitope reconstitution with peptides extracted from HLA-Aw68 by Slingluff (1994)
  21. 10.1007/BF00375376 / Immunogenetics. / Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids by Salter (1985)
  22. 10.1126/science.1546329 / Science. / HLA-A2.1-associated peptides from a mutant cell linea second pathway of antigen presentation by Henderson (1992)
  23. 10.4049/jimmunol.152.8.3862 / J. Immunol. / Association of human class I MHC alleles with the adenovirus E3/19K protein by Beier (1994)
  24. 10.4049/jimmunol.134.6.4218 / J. Immunol. / Construction of novel class I histocompatibility antigens by interspecies exon shuffling by Engelhard (1985)
  25. 10.1016/0198-8859(81)90065-3 / Hum. Immunol. / Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28 by Parham (1981)
  26. 10.4049/jimmunol.123.1.342 / J. Immunol. / Use of a monoclonal antibody (W6/32) in structural studies of HLA-A, B, C antigens by Parham (1979)
  27. 10.1111/j.1399-0039.1983.tb01176.x / Tissue Antigens. / Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies by Rebai (1983)
  28. 10.1021/ac000497v / Anal. Chem. / Sub-femtomole MS and MS/MS peptide sequence analysis using nano-HPLC micro-ESI fourier transform ion cyclotron resonance mass spectrometry by Martin (2000)
  29. 10.1016/S1044-0305(98)00088-9 / J. Am. Soc. Mass Spectrom. / Fragmentation of phosphopeptides in an ion trap mass spectrometer by DeGnore (1998)
  30. 10.4049/jimmunol.156.7.2473 / J. Immunol. / Importance of MHC class 1 α2 and α3 domains in the recognition of self and non-self MHC molecules by Newberg (1996)
  31. 10.4049/jimmunol.164.5.2354 / J. Immunol. / The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice by Bullock (2000)
  32. 10.1084/jem.191.7.1221 / J. Exp. Med. / Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigenimplications for tumor immunotherapy by Colella (2000)
  33. 10.4049/jimmunol.152.6.2874 / J. Immunol. / Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations by Chen (1994)
  34. 10.1016/1046-5928(92)90001-D / Protein Expr. Purif. / Immobilized metal ion affinity chromatography by Porath (1992)
  35. 10.1016/S0021-9258(18)43911-7 / J. Biol. Chem. / Identification by electrospray ionization mass spectrometry of the sites of tyrosine phosphorylation induced in activated Jurkat T cells on the protein tyrosine kinase ZAP-70 by Watts (1994)
  36. 10.1006/abio.1996.0313 / Anal. Biochem. / Selective detection and sequencing of phosphopeptides at the femtomole level by mass spectrometry by Carr (1996)
  37. 10.1021/ac950875+ / Anal. Chem. / Parent ion scans of unseparated peptide mixtures by Wilm (1996)
  38. 10.1084/jem.181.4.1481 / J. Exp. Med. / Processing of major histocompatibility class I–restricted antigens in the endoplasmic reticulum by Elliott (1995)
  39. 10.1002/(SICI)1097-0282(1998)47:3<197::AID-BIP2>3.0.CO;2-H / Biopolymers. / Protein tyrosine kinasesstructure, substrate specificity, and drug discovery by al-Obeidi (1998)
  40. 10.1074/jbc.274.51.36472 / J. Biol. Chem. / Phosphorylation-dependent conformational changes induce a switch in the actin-binding function of MARCKS by Bubb (1999)
  41. {'key': '2023072509173878700_R41', 'first-page': '5785', 'article-title': 'Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene', 'volume': '59', 'author': 'Chiari', 'year': '1999', 'journal-title': 'Cancer Res.'} / Cancer Res. / Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene by Chiari (1999)
  42. 10.1016/0092-8674(91)90639-G / Cell. / Oncogenes and signal transduction by Cantley (1991)
  43. 10.1016/0092-8674(91)90637-E / Cell. / Cooperation between oncogenes by Hunter (1991)
  44. 10.1146/annurev.iy.12.040194.001145 / Annu. Rev. Immunol. / Structure of peptides associated with class I and class II MHC molecules by Engelhard (1994)
  45. 10.1006/smim.1993.1012 / Semin. Immunol. / Consensus motifs and peptide ligands of MHC class I molecules by Falk (1993)
  46. 10.1016/0968-0004(90)90073-K / Trends Biochem. Sci. / Protein kinase recognition sequence motifs by Kemp (1990)
  47. 10.1038/nm0398-321 / Nat. Med. / Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma by Rosenberg (1998)
  48. 10.1007/BF00820664 / Springer Semin. Immunopathol. / Direct identification of tumor-associated peptide antigens by Engelhard (1996)
  49. 10.1016/S1074-7613(00)80101-6 / Immunity. / The makings of a tumor rejection antigen by Gilboa (1999)
  50. 10.1016/S0021-9258(17)37101-6 / J. Biol. Chem. / Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases by Milne (1994)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 12:48 p.m.)
Deposited 2 years, 1 month ago (July 25, 2023, 6:32 a.m.)
Indexed 1 week, 6 days ago (Aug. 19, 2025, 6:44 a.m.)
Issued 24 years, 8 months ago (Dec. 18, 2000)
Published 24 years, 8 months ago (Dec. 18, 2000)
Published Online 24 years, 8 months ago (Dec. 18, 2000)
Published Print 24 years, 8 months ago (Dec. 18, 2000)
Funders 0

None

@article{Zarling_2000, title={Phosphorylated Peptides Are Naturally Processed and Presented by Major Histocompatibility Complex Class I Molecules in Vivo}, volume={192}, ISSN={1540-9538}, url={http://dx.doi.org/10.1084/jem.192.12.1755}, DOI={10.1084/jem.192.12.1755}, number={12}, journal={The Journal of Experimental Medicine}, publisher={Rockefeller University Press}, author={Zarling, Angela L. and Ficarro, Scott B. and White, Forest M. and Shabanowitz, Jeffrey and Hunt, Donald F. and Engelhard, Victor H.}, year={2000}, month=dec, pages={1755–1762} }